| CAS No. | 57576-44-0 |
|---|---|
| MDL No. | MFCD00866250 |
| MF | C42H53NO15 |
| MW | 811.90 |
| InChI Key | USZYSDMBJDPRIF-SVEJIMAYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | ≥98% | $203 | In Stock | |
| 5 mg | To Be Confirmed | $441 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Aclacinomycin A is an anthracycline antibiotic produced by *Streptomyces galilaeus* with potent antineoplastic activity. It functions as an antimicrobial agent, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an apoptosis inducer, and an antineoplastic agent. It is a bacterial metabolite and belongs to the classes of aminoglycosides, trisaccharide derivatives, polyketides, phenols, methyl esters, and tetracenequinones. It is functionally related to aklavinone and is a conjugate base of aclacinomycin A(1+), as well as a tautomer of aclacinomycin A zwitterion.
| CAS No. | 57576-44-0 |
|---|---|
| Product Name | Aclarubicin |
